TYPE 2 PLASMINOGEN ACTIVATOR INHIBITOR
\tˈa͡ɪp tˈuː plˈazmɪnəd͡ʒən ˈaktɪvˌe͡ɪtəɹ ɪnhˈɪbɪtə], \tˈaɪp tˈuː plˈazmɪnədʒən ˈaktɪvˌeɪtəɹ ɪnhˈɪbɪtə], \t_ˈaɪ_p t_ˈuː p_l_ˈa_z_m_ɪ_n_ə_dʒ_ə_n ˈa_k_t_ɪ_v_ˌeɪ_t_ə_ɹ ɪ_n_h_ˈɪ_b_ɪ_t_ə]\
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
Nearby Words
- type 1 spinocerebellar ataxia
- type 2 duane retraction syndrome
- type 2 gaucher disease
- type 2 neurofibromatoses
- type 2 neurofibromatosis
- Type 2 Plasminogen Activator Inhibitor
- type 2 spinocerebellar ataxia
- type 3 duane retraction syndrome
- type 3 gaucher disease
- type 3 hereditary sensory neuropathy, dominant
- type 3 plasminogen activator inhibitor